Cite

1. BURNS A, ZAUDIG M. Mild cognitive impairment in older people. Lancet 2002; 360(9349):1963-1965.10.1016/S0140-6736(02)11920-9Search in Google Scholar

2. AKSENOV MY, AKSENOVA MV, BUTTERFIELD DA. Protein oxidation in the brain in Alzheimer’s disease. Neuroscience 2001; 103(2):373-383.10.1016/S0306-4522(00)00580-7Search in Google Scholar

3. BUTTERFIELD DA, CM LAUDERBACK. Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress. Free Radic Biol Med 2002; 32(11):1050-1060.10.1016/S0891-5849(02)00794-3Search in Google Scholar

4. LI JC, KAMINSKAS E. Deficient repair of DNA lesions in alzheimer’s disease fibroblasts. Biochem Biophys Res Commun 1985; 129(3):733-738.10.1016/0006-291X(85)91953-9Search in Google Scholar

5. SAYRE LM, ZELASKO DA, HARRIS PL. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer’s disease. J Neurochem 1997; 68(5):2092-2097.10.1046/j.1471-4159.1997.68052092.xSearch in Google Scholar

6. HARDY J, ALLSOP D. Amyloid deposition as the central event in the aetiology of Alzheimer’s disease. Trends Pharmacol Sci 1991; 12:383-388.10.1016/0165-6147(91)90609-VSearch in Google Scholar

7. ZHANG YW, THOMPSON R, ZHANG H. APP processing in Alzheimer’s disease. Mol Brain 2011; 4(1):3.10.1186/1756-6606-4-3Search in Google Scholar

8. DYRKS T, DYRKS E, HARTMANN T. Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J Biol Chem 1992; 267(25):18210-17.10.1016/S0021-9258(19)37174-1Search in Google Scholar

9. K HENSLEY, JM CARNEY, MP MATTSON. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci 1994; 91(8):3270-3274.10.1073/pnas.91.8.3270435588159737Search in Google Scholar

10. BUTTERFIELD DA, HENSLEY K, HARRIS M. β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: Implications to Alzheimer’s disease. Biochem Biophys Res Commun 1994; 200(2):710-715.10.1006/bbrc.1994.15088179604Search in Google Scholar

11. NUNOMURA A, PERRY G, ALIEV G, HIRAI K, TAKEDA A, BALRAJ EK et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 2001; 60(8):759-767.10.1093/jnen/60.8.759Search in Google Scholar

12. NUNOMURA A, CHIBA S, LIPPA CF, CRAS P, KALARIA RN, TAKEDA A et al. Neuronal RNA oxidation is a prominent feature of familial Alzheimer’s disease. Neurobiol Dis 2004; 17(1):108-113.10.1016/j.nbd.2004.06.003Search in Google Scholar

13. MOREIRA PI, SANTOS MS, OLIVEIRA CR, SHENK JC, NUNOMURA A, SMITH MA et al. Alzheimer disease and the role of free radicals in the pathogenesis of the disease. CNS Neurol Disord Drug Targets 2008; 7(1):3-10.10.2174/187152708783885156Search in Google Scholar

14. KONTUSH A, BERNDT C, WEBER W, AKOPYAN V, ARLT S, SCHIPPLING S et al. Amyloid-β is an antioxidant for lipoproteins in cerebrospinal fluid and plasma. Free Radic Biol Med 2001; 30(1):119-128.10.1016/S0891-5849(00)00458-5Search in Google Scholar

15. LOVELL MA, ROBERTSON JD, TEESDALE WJ, CAMPBELL JL, MARKESBERY WR. Copper, iron and zinc in Alzheimer’s disease senile plaques. J Neurol Sci 1998; 158(1):47-52.10.1016/S0022-510X(98)00092-6Search in Google Scholar

16. Castellani RJ, Rolston RK, Smith MA. Alzheimer disease. Dis Mon 2010; 56(9):484.10.1016/j.disamonth.2010.06.001294191720831921Search in Google Scholar

17. RAMOS MI, ALLEN LH, MUNGAS DM, JAGUST WJ, HAAN MN, GREEN R et al. Low folate status is associated with impaired cognitive function and dementia in the Sacramento Area Latino Study on Aging. Am J Clin Nutr 2005; 82(6):1346-1352.10.1093/ajcn/82.6.134616332669Search in Google Scholar

18. QUADRI P, FRAGIACOMO C, PEZZATI R, ZANDA E, FORLONI G, TETTAMANTI M et al. Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr 2004; 80(1):114-122.Search in Google Scholar

19. TUCKER KL, QIAO N, SCOTT T, ROSENBERG I, SPIRO A. High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am J Clin Nutr 2005; 82(3):627-635.10.1093/ajcn/82.3.627Search in Google Scholar

20. MILLER, A.L. The methionine-homocysteine cycle and its effects on cognitive diseases. Altern Med Rev 2003; 8(1):7-19.Search in Google Scholar

21. BOLDYREV A. Molecular mechanisms of homocysteine toxicity and possible protection against hyperhomocysteinemia. Recent advances on nutrition and the prevention of Alzheimer’s disease. Trivandrum, India: Transworld Research Network 2010; 127-43.Search in Google Scholar

22. HOSSEINI SR, CUMMING RG, KHEIRKHAH F, NOOREDDINI H, BAJANI M, MIKANIKI E et al. Cohort profile: The Amirkola health and ageing project (AHAP). Int J Epidemiol 2014; 43(5):1393-40010.1093/ije/dyt08923918798Search in Google Scholar

23. PETERSEN RC, NEGASH S. Mild cognitive impairment: an overview. CNS Spectr 2008; 13(1):45.10.1017/S1092852900016151Search in Google Scholar

24. PRICE JL, KO AI, WADE MJ, TSOU SK, MCKEEL DW, MORRIS JC. Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. Arch Neurol 2001; 58(9):1395-1402.10.1001/archneur.58.9.1395Search in Google Scholar

25. GRAY SL, HANLON JT, LANDERMAN LR, ARTZ M, SCHMADER KE, FILLENBAUM GG. Is antioxidant use protective of cognitive function in the community-dwelling elderly? Am J Geriatr Pharmacother 2003; 1(1): 3-10.Search in Google Scholar

26. MAYNARD CJ, BUSH AI, MASTERS CL, CAPPAI R, LI QX. Metals and amyloid-β in Alzheimer’s disease. Int J Exp Pathol 2005; 86(3):147-159.10.1111/j.0959-9673.2005.00434.xSearch in Google Scholar

27. MASSIE HR, AIELLO VR, IODICE AA. Changes with age in copper and superoxide dismutase levels in brains of C57BL/6J mice. Mech Ageing Dev 1979; 10(1):93-99.10.1016/0047-6374(79)90073-3Search in Google Scholar

28. MAYNARD CJ, CAPPAI R, VOLITAKIS I, CHERNY RA, WHITE AR, BEYREUTHER K et al. Overexpression of Alzheimer’s disease amyloid-β opposes the age-dependent elevations of brain copper and iron. J Biol Chem 2002; 277(47):44670-44676.10.1074/jbc.M20437920012215434Search in Google Scholar

29. ROOS PM, VESTERBERG O, NORDBERG M. Metals in motor neuron diseases. Exp Biol Med (Maywood) 2006; 231(9):1481-1487.10.1177/15353702062310090617018870Search in Google Scholar

30. HA C, RYU J, PARK CB. Metal ions differentially influence the aggregation and deposition of Alzheimer’s β-amyloid on a solid template. Biochemistry 2007; 46(20):6118-6125.10.1021/bi700003217455909Search in Google Scholar

31. ZUCCONI GG, CIPRIANI S, SCATTONI R, BALGKOURANIDOU I, HAWKINS DP, RAGNARSDOTTIR KV. Copper deficiency elicits glial and neuronal response typical of neurodegenerative disorders. Neuropathol Appl Neurobiol 2007; 33(2):212-225.10.1111/j.1365-2990.2006.00793.x17359362Search in Google Scholar

32. LUTSENKO S, BARNES NL, BARTEE MY, DMITRIEV OY. Function and regulation of human copper-transporting ATPases. Physiol Rev 2007; 87(3):1011-1046.10.1152/physrev.00004.200617615395Search in Google Scholar

33. TAYLOR JP, HARDY J, FISCHBECK KH. Toxic proteins in neurodegenerative disease. Science 2002; 296(5575):1991-1995.10.1126/science.106712212065827Search in Google Scholar

34. GOLBAHAR J, BARARPOUR H. Normal range of total plasma homocysteine concentrations in southern Iran. IJMS 2003; 28:139-42.Search in Google Scholar

35. COLLABORATION H.S. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002; 288(16):2015-2022.10.1001/jama.288.16.201512387654Search in Google Scholar

36. TEMPLE ME, LUZIER AB, KAZIERAD DJ. Homocysteine as a risk factor for atherosclerosis. Ann Pharmacother 2000; 34(1):57-65.10.1345/aph.1845710669187Search in Google Scholar

37. ZHAO L, YAN Y, WANG Y, CAI Z. Homocysteine Contributes to Pathogenesis by Oxidative stress for Alzheimer’s disease. Aging and Neurodegeneration 2013; 1:1.Search in Google Scholar

eISSN:
1220-4749
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Clinical Medicine, Internal Medicine, other, Cardiology, Gastroenterology, Rheumatology